HALO logo
halo search icon
Milestone Pharmaceuticals, Inc.

US$1.50

Price Change Indicator
0.07 (4.90%)
Milestone Pharmaceuticals, Inc.
MIST · NAS

Milestone Pharmaceuticals, Inc.

Start Trading MIST for Free

US$1.50

Price Arrow0.07 (4.90%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownExtreme OversoldHALO AllHALO Consensus ValueHammer BullishHammer Bullish (Realtime)+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Milestone Pharmaceuticals, Inc. Overview

MIST Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MIST

icon
icon

Telephone

1.514.336.0444

icon

Address

Suite 420, 1111 Dr. Frederik-Philips Boulevard, Montréal, QC H4M 2X6

Description

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.

MIST Price Chart

Key Stats

Market Cap

US$178.03M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1 - 3.06

Trade Value (12mth)

US$1,265,715.00

1 week

-4.98%

1 month

-25.52%

YTD

-30.24%

1 year

3.62%

All time high

27.95

Key Fundamentals

EPS 3 yr Growth

-45.30%

EBITDA Margin

NaN%

Operating Cashflow

-$49m

Free Cash Flow Return

-58.80%

ROIC

-75.60%

Interest Coverage

-16.30

Quick Ratio

8.00

Other Data

Shares Outstanding (Fully Diluted)

130m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MIST Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

MIST Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.39-0.67-0.75locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.39-0.67-0.75locklocklock
Growth
 %locklocklocklock-152-12.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Milestone Pharmaceuticals, Inc. (MIST:NAS)?
Halo FAQ
The current share price of Milestone Pharmaceuticals, Inc. (MIST:NAS) is USD$1.50.
What is the 52-week high share price for Milestone Pharmaceuticals, Inc. (MIST:NAS)?
Halo FAQ
The 52-week high share price for Milestone Pharmaceuticals, Inc. (MIST:NAS) is USD$3.06.
What is the 52-week low share price for Milestone Pharmaceuticals, Inc. (MIST:NAS)?
Halo FAQ
The 52-week low share price for Milestone Pharmaceuticals, Inc. (MIST:NAS) is USD$1.00.
What is the dividend yield for Milestone Pharmaceuticals, Inc. (MIST:NAS)?
Halo FAQ
Milestone Pharmaceuticals, Inc. (MIST:NAS) does not pay a dividend.
What was Milestone Pharmaceuticals, Inc. (MIST:NAS) last dividend payment?
Halo FAQ
Milestone Pharmaceuticals, Inc. (MIST:NAS) does not pay a dividend.
What is the franking level for Milestone Pharmaceuticals, Inc. (MIST:NAS)?
Halo FAQ
Milestone Pharmaceuticals, Inc. (MIST:NAS) has a franking level of 0.00%.
In which sector is Milestone Pharmaceuticals, Inc. (MIST:NAS) classified?
Halo FAQ
Milestone Pharmaceuticals, Inc. (MIST:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial